ZNF852 inhibitors represent a class of molecules designed to modulate the activity of the zinc finger protein ZNF852, which is a member of a large family of zinc finger (ZNF) transcription factors. Zinc finger proteins are defined by their characteristic structural motifs that allow them to bind to specific DNA sequences, playing a crucial role in gene regulation. ZNF852, like other ZNF proteins, functions as a transcriptional regulator, modulating gene expression by interacting with DNA and influencing the transcriptional machinery. These proteins typically contain zinc finger domains, which coordinate zinc ions to stabilize the structure, enabling their role in DNA binding. ZNF852 inhibitors are molecules that specifically target this transcription factor, modulating its function by interfering with its ability to bind DNA or interact with other proteins. By inhibiting ZNF852, these compounds influence cellular pathways related to the genes under ZNF852 regulation.
The chemical design of ZNF852 inhibitors typically involves the identification of small molecules or peptides that can specifically bind to the active sites or domains of the ZNF852 protein. Structural studies, such as X-ray crystallography or NMR, play a significant role in understanding the protein's conformation and in guiding the rational design of inhibitors. Key considerations in the development of these inhibitors include achieving high specificity for ZNF852 to minimize off-target effects, as well as ensuring that the inhibitor can effectively interfere with the protein-DNA interactions. Some ZNF852 inhibitors are designed to disrupt the zinc finger domain's coordination of zinc ions, altering the protein's structural integrity and functionality. Others may interfere with the interaction between ZNF852 and co-regulatory proteins that assist in gene transcription. The design and study of these inhibitors provide valuable insights into the broader regulatory networks that ZNF852 is involved in, as well as the intricate mechanisms of zinc finger protein activity in general.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
TPEN | 16858-02-9 | sc-200131 | 100 mg | $130.00 | 10 | |
Zinc chelators like TPEN might indirectly affect ZNF852 by altering zinc availability, crucial for the function of zinc finger proteins. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
HDAC inhibitors such as Trichostatin A could indirectly influence ZNF852 by modifying chromatin structure and gene expression. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
5-Azacytidine may affect ZNF852 indirectly by altering gene expression patterns through DNA methylation changes. | ||||||
Ruxolitinib | 941678-49-5 | sc-364729 sc-364729A sc-364729A-CW | 5 mg 25 mg 25 mg | $251.00 $500.00 $547.00 | 16 | |
JAK/STAT inhibitors like Ruxolitinib could indirectly impact ZNF852 by modulating pathways involved in gene expression and cell signaling. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin, a PI3K/Akt/mTOR inhibitor, might affect ZNF852 indirectly by altering signaling pathways that intersect with DNA binding and gene regulation. | ||||||
(±)-JQ1 | 1268524-69-1 | sc-472932 sc-472932A | 5 mg 25 mg | $231.00 $863.00 | 1 | |
Bromodomain inhibitors like JQ1 may influence ZNF852 indirectly by affecting transcription regulation and chromatin remodeling. | ||||||
17-AAG | 75747-14-7 | sc-200641 sc-200641A | 1 mg 5 mg | $67.00 $156.00 | 16 | |
HSP90 inhibitors like 17-AAG could indirectly influence ZNF852 by affecting protein stability and function. | ||||||
Pladienolide B | 445493-23-2 | sc-391691 sc-391691B sc-391691A sc-391691C sc-391691D sc-391691E | 0.5 mg 10 mg 20 mg 50 mg 100 mg 5 mg | $299.00 $5699.00 $11099.00 $25500.00 $66300.00 $2875.00 | 63 | |
Splicing inhibitors such as Pladienolide B may indirectly impact ZNF852 by altering RNA splicing processes. | ||||||
α-Amanitin | 23109-05-9 | sc-202440 sc-202440A | 1 mg 5 mg | $269.00 $1050.00 | 26 | |
α-Amanitin, an RNA polymerase inhibitor, could indirectly affect ZNF852 by impacting RNA synthesis and processing. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
Proteasome inhibitors like Bortezomib may influence ZNF852 indirectly by modulating protein degradation pathways. | ||||||